Business / Finance

RSS

Cardo and Arthrex enter Asset Purchase Agreement

Cardo Medical, Inc., an orthopedic medical device company based in Los Angeles, California, its wholly-owned subsidiary, Cardo Medical, LLC, and Arthrex, Inc., a leading provider of sports medicine product development and educational services for orthopedic surgeons based in Naples, Florida, announced today that they signed an asset purchase agreement.

25 Jan 2011

Dr. Reddy’s third quarter consolidated revenues increase 10% to $424 million

Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the quarter ended December 31st, 2010 under International Financial Reporting Standards (IFRS).

25 Jan 2011

Trust in business, government shows marked resilience: 2011 Edelman Trust Barometer

In a year marred by corporate crises and financial turmoil for European governments, trust in business and government showed marked resilience, according to the 2011 Edelman Trust Barometer. Trust in business saw a two-point global increase, surging in Brazil, rising in Germany, and holding steady in China and India. The United States was the outlier, as trust dropped across all institutions – business, government, NGOs, and media.

25 Jan 2011

Diamyd Medical reports first quarter group total net sales of MSEK 144.5

Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.

25 Jan 2011

NEPAD, GAIN sign Memorandum of Understanding to reduce malnutrition in Africa

The Global Alliance for Improved Nutrition and the New Partnership for Africa Development today announced the signing of a Memorandum of Understanding to significantly contribute to reducing malnutrition in Africa.

25 Jan 2011

XIRING and SCM Microsystems enter strategic cooperation agreement

XIRING, a security solutions provider for electronic transactions, and SCM Microsystems, a business unit of Identive Group, Inc. and a global leader in security and identity solutions for secure access, secure identity and secure exchange, announced today that they have entered into a strategic cooperation agreement that expands their existing successful partnership.

25 Jan 2011

Myriant closes $60M strategic equity investment from PTT Chemical

Myriant Technologies, Inc., a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announced today the closing of a $60 million strategic equity investment from PTT Chemical Group, Thailand's largest petrochemical producer.

24 Jan 2011

NYSE Amex accepts Cardium's exchange listing compliance plan

Cardium Therapeutics reported that its exchange listing compliance plan submitted on December 2, 2010 has been accepted by the NYSE Amex LLC.

24 Jan 2011

PediatRx announces first-ever revenues and successful launch of GRANISOL

PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.

24 Jan 2011

HealthStream, Laerdal launch Simcenter simulation management platform for healthcare institutions

Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The

From Laerdal 24 Jan 2011

Digital Assent closes $2 million Series A equity financing round

Atlanta-based Digital Assent, provider of the PatientPad self-service patient check-in and patient education solution, announces the closing of a $2 million Series A round of equity financing led by Imlay Investments, Fulcrum Equity Partners and BLH Venture Partners.

24 Jan 2011

American Scientific Resources now quoted on OTCQB market

American Scientific Resources, Inc. wishes to announces that it is now quoted on the OTCQB market.

24 Jan 2011

Hitachi Medical Systems America achieves top ranking among MRI vendors

In the 2010 Q4 User Satisfaction Survey, MD Buyline users have named Hitachi Medical Systems America (HMSA) the top rated MRI vendor. HMSA swept the top rankings in all six categories and earned a composite score 9.6 out of 10.

24 Jan 2011

Medisafe 1 Technologies' 2012 revenues to exceed $10M

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed $10M .

24 Jan 2011

AnC Bio Holdings invests $4 million in Bioheart

Bioheart, Inc. announced today that it has entered into an agreement with AnC Bio Holdings, Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.

24 Jan 2011

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

BioDelivery Sciences International, Inc. today responded to a process patent infringement lawsuit filed and recently served against the Company and certain co-defendants by MonoSol Rx, LLC. The purpose in responding at this time is for BDSI to strongly refute MonoSol's claims and to assure BDSI stockholders that the Company remains focused on vigorously progressing its pipeline and not allowing this claim to present a distraction.

24 Jan 2011

Radiation Therapy Services to issue $50M of 9-7/8% Senior Subordinated Notes due 2017

Radiation Therapy Services Holdings, Inc.announced today that its wholly owned subsidiary, Radiation Therapy Services, Inc., has agreed to issue an aggregate principal amount of $50 million of 9-7/8% Senior Subordinated Notes due 2017.

24 Jan 2011

Novartis enters definitive merger agreement to acquire Genoptix

Genoptix, announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share.

24 Jan 2011

Teva Pharmaceutical announces entry into new three-year credit facility

Teva Pharmaceutical Industries Ltd. announced today that it has entered into a new three-year, $1.5 billion unsecured revolving credit facility, which replaces and expands existing credit lines at terms that are more favorable to Teva.

24 Jan 2011

CRI, Oncovir sign new investment agreement to produce immunological stimulant

Cancer Research Institute, a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund, a joint initiative with the Ludwig Institute for Cancer Research, has completed a new investment agreement with Oncovir, a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol- (Poly-ICLC).

24 Jan 2011